Applications of Streptococcus-derived Cas9 nucleases on minimal Adenine-rich PAM targets
AssigneeMassachusetts Institute of Technology
InventorsPranam Chatterjee, Noah Michael Jakimo, Joseph M. Jacobson
Life of this patent
Estimating the term…
Loading patent…
AssigneeMassachusetts Institute of Technology
InventorsPranam Chatterjee, Noah Michael Jakimo, Joseph M. Jacobson
Estimating the term…
Applications of a Streptococcus Cas9 ortholog from Streptococcus macacae (Smac Cas9), possessing minimal adenine-rich PAM specificity, include an isolated Streptococcus macacae Cas9 protein or transgene expression thereof, a CRISPR-associated DNA endonuclease with PAM interacting domain amino acid sequences that are at least 80% identical to that of the isolated Streptococcus macacae Cas9 protein, and an isolated, engineered Streptococcus pyogenes Cas9 (Spy Cas9) protein with a PID as either the PID amino acid composition of the isolated Streptococcus macacae Cas9 (Smac Cas9) protein or of a CRISPR-associated DNA endonuclease with PID amino acid sequences that are at least 80% identical to that of the isolated Streptococcus macacae Cas9 protein. A method for altering expression of at least one gene product employs Streptococcus macacae Cas9 endonucleases in complex with guide RNA, for specific recognition and activity on a DNA target immediately upstream of either an “NAA” or “NA” or “NAAN” PAM sequence.
An isolated, engineered Streptococcus pyogenes Cas9 (SpyCas9) protein comprising SEQ ID No:
A method of altering expression of at least one gene product comprising:
Dependencies are inferred from the claim text.